Double-blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants < 4 months of age

British Journal of Dermatology

Volumn 169, Issue 1, 2013, Pages 181-183

  Leaute Labreze C ^a   Dumas De La Roque, E ^b   Nacka, F ^c   Abouelfath, A ^b   Grenier, N ^c   Rebola, M ^c   Ezzedine, K ^a   Moore, N ^b  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b Centre of Clinical Investigation Clinical Epidemiology   (France)

^c HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETORPHAN; ALPHA INTERFERON; BICARBONATE; CORTICOSTEROID; GAVISCON; PARACETAMOL; PLACEBO; PROPRANOLOL; STEROID; TRIMEBUTINE; TRIMEBUTINE MALEATE; VINCRISTINE; ANTINEOPLASTIC AGENT;

BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE MEASUREMENT; COMPASSIONATE USE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; EARLY INTERVENTION; FUNCTIONAL DISEASE; HEART RATE; HEMANGIOMA; HUMAN; INFANT DISEASE; LETTER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THICKNESS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; CICATRIX; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEAD AND NECK NEOPLASMS; INFANT; MALE; NEWBORN; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN NEOPLASMS; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CICATRIX; DOUBLE-BLIND METHOD; FEMALE; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; MALE; PILOT PROJECTS; PROPRANOLOL; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84879926921     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12217     Document Type: Letter

References (9)

1. Léauté-Labrèze C, Dumas De La Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-51.
2. Sans V, Dumas de la Roque E, Berge J, et al. Propranolol for severe infantile hemangiomas: a follow-up report. Pediatrics 2009; 124: e423-31.
3. Manunza F, Syed S, Laguda B, et al. Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol 2010; 162: 466-8.
4. Bertrand J, McCuaig C, Dubois J, et al. Propranolol versus prednisone in the treatment of infantile hemangiomas: a retrospective comparative study. Pediatr Dermatol 2011; 28: 649-54.
5. Izadpanah A, Izadpanah A, Kanevsky J, et al. Propranolol versus corticosteroids in the treatment of infantile hemangioma; a systematic review and meta-analysis. Plast Reconstr Surg 2012; 131: 601-13.
6. Hogeling M, Adams S, Wargon O,. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics 2011; 128: e259-66.
7. Tollefson MM, Frieden IJ,. Early growth of infantile hemangiomas: what parents' photographs tell us. Pediatrics 2012; 130: e314-20.
8. Léauté-Labrèze C, Prey S, Ezzedine K,. Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J Eur Acad Dermatol Venereol 2011; 25: 1245-53.
9. Léauté-Labrèze C, Prey S, Ezzedine K,. Infantile haemangioma: part II. Risks, complications and treatment. J Eur Acad Dermatol Venereol 2011; 25: 1254-60.